Not Yet Recruiting PHASE2/PHASE3 INTERVENTIONAL 3-arm NCT06681194

Silver Nitrate vs. Triamcinolone for Treatment of Hypergranulation Tissue

A Comparative Study of Silver Nitrate, Triamcinolone, and Their Successive Combined Use on Hypergranulation Tissue in Traumatic Wounds: A Randomized Control Trial

Sponsor: Francesco Egro

Conditions Granulation Tissue Wound Healing

Interventions Silver Nitrate Silver nitrate + triamcinolone triamcinolone

Updated 3 times since 2024 Last updated: Mar 5, 2025 Started: Jun 1, 2025 Primary completion: Dec 31, 2028 Completion: Dec 31, 2028

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06681194, this PHASE2/PHASE3 trial focuses on Granulation Tissue and Wound Healing and remains actively recruiting participants. Sponsored by Francesco Egro, it has been updated 3 times since 2025, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

3 versions recorded

Jun 2025 — Present [monthly]

Not Yet Recruiting PHASE2/PHASE3
Apr 2025 — Jun 2025 [monthly]

Not Yet Recruiting PHASE2/PHASE3
Dec 2024 — Apr 2025 [monthly]

Not Yet Recruiting PHASE2/PHASE3

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Francesco Egro

Data source: University of Pittsburgh

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Pittsburgh, United States